application and how is it impacting the global drug development? In 2012, Congress created the breakthrough-therapy designation to expedite the testing and approval by the FDA, of medications with ... meant to treat the…
generic topical drug products. They can also be used during the formulation development phase of both new and generic topicals to assess the relative bioavailability of various test formulations ... rate of release…
attendees of this lecture will be familiarized with the need for rigorous and stringent testing of candidate carrier system, so that only the most promising therapies are advanced to clinical ... efficacy when treating…
genetic variations (mutations). Hepatic gene variation controls how we respond to a drug. With a simple test called a pharmacogenetics (PGx), a doctor can observe this genetic activity
genetic variations (mutations). Hepatic gene variation controls how we respond to a drug. With a simple test called a pharmacogenetics (PGx), a doctor can observe this genetic activity
genetic variations (mutations). Hepatic gene variation controls how we respond to a drug. With a simple test called a pharmacogenetics (PGx), a doctor can observe this genetic activity
research is to develop standardize analytical technique for in-vitro performance testing of initial first line therapy antihypertensive drugs (amlodipine besilate and enalapril maleate) in combined dosage forms by…
tested for chemopreventive activity of two natural phytochemicals like catechin. a natural phenol and antioxidant from Saraca asoca (Roxb.) and monotarpenes from Ocimum basilicum L comparing with known chemotherapeutic…
Brazilian Health Surveillance Agency (Anvisa), European Medicines Agency (EMA) and Food and Drug Administration (FDA), comparative dissolution testing is required as a previous stage to the bioequivalence study between…
research is to develop standardized analytical technique for in-vitro performance testing of initial first line therapy antihypertensive drugs (amlodipine besilate and enalapril maleate) in combined dosage forms by…
hybrid nanoparticulate drug delivery system (DDS) consisting of a liposomal core coated with alternate layers of alginate and chitosan was developed by our group for the purpose of delivering Bone ... target and…
same sensitivity pattern but carbapenems were all reported resistant. Manual ESBL and Modified Hodge tests were performed according to the CLSI and ESCMID guidelines. Both yielded negative. Sample was sent ... other…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.